Post-acute sequelae of COVID-19 (PASC," Long COVID") pose a significant global health
challenge. The pathophysiology is unknown, and no effective treatments have been found to …

The type I interferon (IFN) response is the body's typical immune defense against viruses.
Previous studies linked high expression of genes encoding type I IFNs in the brain's choroid …

Abstract According to the World Health Organization, severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) has already infected more than 400 million people and …

Can SARS-CoV-2 hitchhike on the olfactory projection and take a direct and short route from
the nose into the brain? We reasoned that the neurotropic or neuroinvasive capacity of the …

Severe neurological symptoms are associated with Coronavirus disease 2019 (COVID-19).
However, the morphologic features, pathological nature and their potential mechanisms in …

Background: There is an urgent need to better understand the mechanisms underlying acute
and long-term neurological symptoms after COVID-19. Neuropathological studies can …

Introduction The pandemic coronavirus disease 19 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and is marked by thromboembolic …

SARS-CoV-2 infection frequently causes neurological impairment in both adults and
children. Recent publications have described significant aspects of the viral pathophysiology …

Neurological symptoms, including cognitive impairment and fatigue, can occur in both the
acute infection phase of coronavirus disease 2019 (COVID-19) and at later stages, yet the …

The reduced pathogenicity of the omicron BA. 1 sub-lineage compared to earlier variants is
well described, although whether such attenuation is retained for later variants like BA. 5 …